ACTINIUM PHARMACEUTICALS INC - COM (ATNM)

CUSIP: 00507W107

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / COM
Total 13F shares
2,522,526
Share change
+73,612
Total reported value
$8,122,000
Price per share
$3.22
Number of holders
24
Value change
+$934,443
Number of buys
12
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 00507W107?
CUSIP 00507W107 identifies ATNM - ACTINIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) as of Q4 2015

As of 31 Dec 2015, ACTINIUM PHARMACEUTICALS INC - COM (ATNM) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,522,526 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, OXFORD ASSET MANAGEMENT, Bank of New York Mellon Corp, BlackRock Fund Advisors, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and D.A. DAVIDSON & CO.. This page lists 24 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.